Stocktoria

BridgeBio Oncology Therapeutics, Inc. BBOT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-02-09

BridgeBio Oncology Therapeutics, Inc. institutional holders

InvestorSharesValue% of company
CITADEL ADVISORS LLC2,617,827$19.9M3.27%
MILLENNIUM MANAGEMENT LLC105,480$803,7580.13%
RENAISSANCE TECHNOLOGIES LLC58,600$446,5320.07%
TWO SIGMA INVESTMENTS, LP26,485$201,8160.03%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.